Downstaging as a direct patient benefit in cancer screening
{{output}}
BackgroundThe standard metric to assess the benefit of cancer screening is reduction in cancer-specific mortality. However, patients may benefit from downstaging of disease due to screening, even among those who would have survived late-stage disease absent sc... ...
